Ticker Details
Alumis Inc. Common Stock
IPO Date:	June 28, 2024
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$3.18B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.41 | 4.17%
Avg Daily Range (30 D):	$0.88 | 3.61%
Avg Daily Range (90 D):	$0.84 | 4.12%

Institutional Daily Volume
Avg Daily Volume:	.81M
Avg Daily Volume (30 D):	1.34M
Avg Daily Volume (90 D):	2.27M

Trade Size
Avg Trade Size (Sh.):	86
Avg Trade Size (Sh.) (30 D):	64
Avg Trade Size (Sh.) (90 D):	84

Institutional Trades
Total Institutional Trades:	336
Avg Institutional Trade:	$1.87M
Avg Institutional Trade (30 D):	$2.55M
Avg Institutional Trade (90 D):	$1.97M
Avg Institutional Trade Volume:	.11M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$3.5M
Avg Closing Trade (30 D):	$4.81M
Avg Closing Trade (90 D):	$3.88M
Avg Closing Volume:	194.06K

News

Apr 14, 2026 @ 5:00 PM The Psoriasis Clinical Trial Pipeline Boom as 90+ ... Source: Delveinsight

Mar 28, 2026 @ 5:30 PM Alumis’ Envudeucitinib Delivers Early and R... Source: Na

Jan 8, 2026 @ 3:52 AM Alumis Announces Pricing of Upsized Public Offerin... Source: Na

Jan 6, 2026 @ 10:12 PM Stock Market Today, Jan. 6: Alumis Shares Surge on... Source: Howard Smith

Jan 5, 2026 @ 10:00 PM Alumis to Host Conference Call and Webcast to Repo... Source: Na

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-2.86	$-.94	$-2.86
Diluted EPS	$-2.86	$-.94	$-2.86
Revenue	$24.05M	$1.93M	$24.05M
Gross Profit
Net Income / Loss	$-243.33M	$-92.93M	$-243.33M
Operating Income / Loss	$-453.8M	$-96.45M	$-453.8M
Cost of Revenue
Net Cash Flow	$-79.58M	$24.42M	$-79.58M
PE Ratio